Literature DB >> 22128656

Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003.

Lindsey Enewold1, Jing Zhou, Susan S Devesa, Ralph L Erickson, Kangmin Zhu, Katherine A McGlynn.   

Abstract

OBJECTIVE: To determine the incidence of testicular germ cell tumors among active duty males and compare it with the incidence in the general U.S. population.
METHODS: The Automated Cancer Tumor Registry and the Surveillance, Epidemiology, and End Results Program data from 1990 to 2003 were analyzed for men aged between 20 and 59 years by histology and stage at diagnosis. Rates were age adjusted using the male active duty military population as the standard.
RESULTS: Nonseminoma incidence was significantly lower in the military than in the general population (incidence rate ratio = 0.90, 95% confidence interval = 0.82-0.98). Trends in incidence tended to be similar in both the populations. Increases were observed for both histologic types but were only significant for seminoma (Automated Cancer Tumor Registry: 21% and Surveillance, Epidemiology, and End Results program: 16%; p < 0.05). Increases in incidence were only observed for localized tumors of both histologic types.
CONCLUSIONS: The lower incidence of nonseminoma in the military and the increased incidence of localized tumors in both populations remain unexplained.

Entities:  

Mesh:

Year:  2011        PMID: 22128656      PMCID: PMC4148906          DOI: 10.7205/milmed-d-10-00476

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  9 in total

Review 1.  Environmental and host factors in testicular germ cell tumors.

Authors:  K A McGlynn
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

2.  Increasing incidence of testicular germ cell tumors among black men in the United States.

Authors:  Katherine A McGlynn; Susan S Devesa; Barry I Graubard; Philip E Castle
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

3.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

4.  Increased incidence of testicular cancer in active duty members of the Department of Defense.

Authors:  I M Thompson; S Optenberg; R Byers; M Dove
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

5.  Efficient interval estimation for age-adjusted cancer rates.

Authors:  Ram C Tiwari; Limin X Clegg; Zhaohui Zou
Journal:  Stat Methods Med Res       Date:  2006-12       Impact factor: 3.021

6.  Trends in testicular germ cell tumours by ethnic group in the United States.

Authors:  Mona N Shah; Susan S Devesa; Kangmin Zhu; Katherine A McGlynn
Journal:  Int J Androl       Date:  2007-08

7.  Trends in the incidence of testicular germ cell tumors in the United States.

Authors:  Katherine A McGlynn; Susan S Devesa; Alice J Sigurdson; Linda M Brown; Lilian Tsao; Robert E Tarone
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

8.  Cancer incidence in the U.S. military population: comparison with rates from the SEER program.

Authors:  Kangmin Zhu; Susan S Devesa; Hongyu Wu; Shelia Hoar Zahm; Ismail Jatoi; William F Anderson; George E Peoples; Larry G Maxwell; Elder Granger; John F Potter; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

9.  Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.

Authors:  Daniel E Cooper; James O L'esperance; Matthew S Christman; Brian K Auge
Journal:  J Urol       Date:  2008-06-12       Impact factor: 7.450

  9 in total
  2 in total

Review 1.  Adolescent and adult risk factors for testicular cancer.

Authors:  Katherine A McGlynn; Britton Trabert
Journal:  Nat Rev Urol       Date:  2012-04-17       Impact factor: 14.432

2.  Increase in testicular germ cell tumor incidence among Hispanic adolescents and young adults in the United States.

Authors:  Franklin L Chien; Stephen M Schwartz; Rebecca H Johnson
Journal:  Cancer       Date:  2014-07-14       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.